Trials / Recruiting
RecruitingNCT06953180
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,720 (estimated)
- Sponsor
- Asfendiyarov Kazakh National Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Conditions
- Cardiovascular Diseases (CVD)
- Type 2 Diabetes
- Chronic Respiratory Diseases
- Obesity (Disorder)
- Chronic Kidney Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Genetic: DNA analysis | Investigation of telomere length (TL) and DNA methylation level analysis |
Timeline
- Start date
- 2025-03-03
- Primary completion
- 2026-01-01
- Completion
- 2026-12-31
- First posted
- 2025-05-01
- Last updated
- 2025-07-11
Locations
1 site across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT06953180. Inclusion in this directory is not an endorsement.